1
|
Gonzalez-Lara L, Bonsang B, Zimmermann U, Blom A, Chapalain M, Tchakerian A, Serra M, Aouidad I, Chaplain L, Roger A, Longvert C, Saiag P, Funck-Brentano E. Formalin-fixed tissue Mohs surgery (slow Mohs) for trichoblastic carcinoma. J Eur Acad Dermatol Venereol 2022; 36:e827-e828. [PMID: 35686623 DOI: 10.1111/jdv.18309] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/21/2022] [Accepted: 05/18/2022] [Indexed: 11/30/2022]
Affiliation(s)
- L Gonzalez-Lara
- Department of Dermatology, Ambroise Paré Hospital, Boulogne-Billancourt, France
| | - B Bonsang
- Research Unit EA 4340 "Biomarkers in Cancerology and in Hemato-oncology", University of Versailles-Saint-Quentin-en-Yvelines, Université Paris-Saclay, Boulogne-Billancourt, France.,Department of Pathology, Ambroise Paré Hospital, Boulogne-Billancourt, France
| | - U Zimmermann
- Research Unit EA 4340 "Biomarkers in Cancerology and in Hemato-oncology", University of Versailles-Saint-Quentin-en-Yvelines, Université Paris-Saclay, Boulogne-Billancourt, France.,Department of Pathology, Ambroise Paré Hospital, Boulogne-Billancourt, France
| | - A Blom
- Department of Dermatology, Ambroise Paré Hospital, Boulogne-Billancourt, France
| | - M Chapalain
- Department of Dermatology, Ambroise Paré Hospital, Boulogne-Billancourt, France
| | - A Tchakerian
- Department of Dermatology, Ambroise Paré Hospital, Boulogne-Billancourt, France
| | - M Serra
- Department of Dermatology, Ambroise Paré Hospital, Boulogne-Billancourt, France
| | - I Aouidad
- Department of Dermatology, Ambroise Paré Hospital, Boulogne-Billancourt, France
| | - L Chaplain
- Department of Dermatology, Ambroise Paré Hospital, Boulogne-Billancourt, France
| | - A Roger
- Department of Dermatology, Ambroise Paré Hospital, Boulogne-Billancourt, France
| | - C Longvert
- Department of Dermatology, Ambroise Paré Hospital, Boulogne-Billancourt, France
| | - P Saiag
- Department of Dermatology, Ambroise Paré Hospital, Boulogne-Billancourt, France.,Research Unit EA 4340 "Biomarkers in Cancerology and in Hemato-oncology", University of Versailles-Saint-Quentin-en-Yvelines, Université Paris-Saclay, Boulogne-Billancourt, France
| | - E Funck-Brentano
- Department of Dermatology, Ambroise Paré Hospital, Boulogne-Billancourt, France.,Research Unit EA 4340 "Biomarkers in Cancerology and in Hemato-oncology", University of Versailles-Saint-Quentin-en-Yvelines, Université Paris-Saclay, Boulogne-Billancourt, France
| |
Collapse
|
2
|
Gonzalez Lara L, Funck-Brentano E, Bonsang B, Zimmermann U, Blom A, Chapalain M, Tchakerien A, Serra M, Aouidad I, Chaplain L, Roger A, Longvert C, Saiag P. Carcinomes trichoblastiques traités par chirurgie micrographique en paraffine. Ann Dermatol Venereol 2020. [DOI: 10.1016/j.annder.2020.09.205] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
3
|
Bouchereau S, Chaplain L, Fort M, Beauchet A, Sidibé T, Chapalain M, Gonzalez-Lara L, Longvert C, Blom A, Aouidad I, Saiag P, Funck-Brentano E. Impact de l’immunothérapie sur l’efficacité de la dacarbazine dans le mélanome métastatique. Ann Dermatol Venereol 2020. [DOI: 10.1016/j.annder.2020.09.066] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/22/2022]
|
4
|
Turquier E, Chaplain L, Fort M, Longvert C, Blom A, Roger A, Chapalain M, Aouidad I, Sidibe T, Beauchet A, Gonzalez-Lara L, Boru B, Saiag P, Funck-Brentano E. Intérêt du PET-scanner avant arrêt des anti-PD-1 dans le mélanome métastatique. Ann Dermatol Venereol 2020. [DOI: 10.1016/j.annder.2020.09.487] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/22/2022]
|
5
|
Funck-Brentano E, Baghad B, Fort M, Aouidad I, Roger A, Beauchet A, Otmezguine Y, Blom A, Longvert C, Boru B, Saiag P. Efficacy of late concurrent hypofractionated radiotherapy in advanced melanoma patients failing anti-PD-1 monotherapy. Int J Cancer 2020; 147:1707-1714. [PMID: 32083739 DOI: 10.1002/ijc.32934] [Citation(s) in RCA: 8] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/06/2019] [Revised: 01/18/2020] [Accepted: 02/07/2020] [Indexed: 12/31/2022]
Abstract
Advanced melanoma patients who failed anti-PD-1 therapy have limited options. We analyzed a cohort of 133 advanced melanoma patients receiving anti-PD-1 monotherapy in a referral center between April 2015 and December 2017, and included the 26 patients with confirmed progressive (PD) or stable disease who received additional radiotherapy with an unmodified anti-PD-1 mAb regimen. Tumor evaluations were done on radiated and nonradiated (RECIST 1.1) lesions, with abscopal effect defined as a partial (PR) or complete response (CR) outside radiated fields. Primary endpoint was the CR + PR rate in radiated + nonradiated lesions. Secondary endpoints were progression-free survival (PFS), melanoma-specific survival (MSS) and safety. First late radiotherapy, consisting of hypofractionated radiotherapy (3-5 sessions, 20-26 Gy), standard palliative radiotherapy or brain radiosurgery was begun after a median of 6.3 months of anti-PD-1 in 23, 2 and 1 patient(s), respectively. Best response was 8 (31%) CR, 2 (8%) profound PR allowing surgical resection of remaining metastases and 16 (62%) PD. Abscopal effect was seen in 35% of patients. Median PFS and MSS since anti-PD-1 initiation was 15.2 [95% CI: 8.0 not achieved (na)] and 35.3 [95% CI: 18.5 na] months, respectively. PFS curves seemed to achieve a plateau. We discontinued anti-PD-1 therapy in 9/10 of patients with no residual evaluable disease and observed one relapse after a median of 10 months off anti-PD1-therapy. No unusual adverse event was recorded. Limitations of the study include its retrospective nature and limited size. Hypofractionated radiotherapy may enhance anti-PD1 monotherapy efficacy in patients who previously failed anti-PD-1 therapy. Controlled studies are needed.
Collapse
Affiliation(s)
- Elisa Funck-Brentano
- Department of General and Oncologic Dermatology, Ambroise-Paré Hospital, APHP & EA 4340 Biomarkers in Cancerology and Hemato-Oncology, UVSQ, Université Paris-Saclay, Paris, France
| | - Bouchra Baghad
- Department of General and Oncologic Dermatology, Ambroise-Paré Hospital, APHP & EA 4340 Biomarkers in Cancerology and Hemato-Oncology, UVSQ, Université Paris-Saclay, Paris, France
| | - Magali Fort
- Department of General and Oncologic Dermatology, Ambroise-Paré Hospital, APHP & EA 4340 Biomarkers in Cancerology and Hemato-Oncology, UVSQ, Université Paris-Saclay, Paris, France
| | - Iman Aouidad
- Department of General and Oncologic Dermatology, Ambroise-Paré Hospital, APHP & EA 4340 Biomarkers in Cancerology and Hemato-Oncology, UVSQ, Université Paris-Saclay, Paris, France
| | - Anissa Roger
- Department of General and Oncologic Dermatology, Ambroise-Paré Hospital, APHP & EA 4340 Biomarkers in Cancerology and Hemato-Oncology, UVSQ, Université Paris-Saclay, Paris, France
| | - Alain Beauchet
- Department of Public Health, Ambroise-Paré Hospital, APHP & UVSQ, Université Paris-Saclay, Paris, France
| | | | - Astrid Blom
- Department of General and Oncologic Dermatology, Ambroise-Paré Hospital, APHP & EA 4340 Biomarkers in Cancerology and Hemato-Oncology, UVSQ, Université Paris-Saclay, Paris, France
| | - Christine Longvert
- Department of General and Oncologic Dermatology, Ambroise-Paré Hospital, APHP & EA 4340 Biomarkers in Cancerology and Hemato-Oncology, UVSQ, Université Paris-Saclay, Paris, France
| | - Blandine Boru
- Department of Radiology, Ambroise-Paré Hospital, APHP, Paris, France
| | - Philippe Saiag
- Department of General and Oncologic Dermatology, Ambroise-Paré Hospital, APHP & EA 4340 Biomarkers in Cancerology and Hemato-Oncology, UVSQ, Université Paris-Saclay, Paris, France
| |
Collapse
|
6
|
Baghad B, Funck-Brentano E, Fort M, Aouidad I, Roger A, Beauchet A, Mazeron JJ, Otmezguine Y, Blom A, Longvert C, Boru B, Saiag P. Association radiothérapie et anti-PD-1 dans le mélanome avancé en cas d’échec d’anti-PD-1 en monothérapie. Ann Dermatol Venereol 2018. [DOI: 10.1016/j.annder.2018.09.527] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
7
|
Aouidad I, Fargeas C, Romero P, Sei JF, Chaussade V, Beauchet A, Clerici T, Zimmermann U, Saiag P, Funck-Brentano E. Histologic predictors of invasion in partially biopsied lentigo maligna melanoma. J Am Acad Dermatol 2018; 80:1150-1152. [PMID: 30879481 DOI: 10.1016/j.jaad.2018.10.036] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/13/2018] [Revised: 10/18/2018] [Accepted: 10/22/2018] [Indexed: 11/15/2022]
Affiliation(s)
- Iman Aouidad
- Research Unit EA 4340 Biomarkers in Cancerology and in Hemato-oncology, University of Versailles-Saint-Quentin-en-Yvelines, Université Paris-Saclay, Boulogne-Billancourt, France; Department of Dermatology, Ambroise Paré Hospital, Boulogne-Billancourt, France.
| | - Céline Fargeas
- Department of Pathology, Ambroise Paré Hospital, Boulogne-Billancourt, France
| | - Pierre Romero
- Research Unit EA 4340 Biomarkers in Cancerology and in Hemato-oncology, University of Versailles-Saint-Quentin-en-Yvelines, Université Paris-Saclay, Boulogne-Billancourt, France; Department of Pathology, Ambroise Paré Hospital, Boulogne-Billancourt, France
| | - Jean-François Sei
- Department of Dermatology, Ambroise Paré Hospital, Boulogne-Billancourt, France
| | - Véronique Chaussade
- Department of Dermatology, Ambroise Paré Hospital, Boulogne-Billancourt, France
| | - Alain Beauchet
- Department of Public Health, Ambroise Paré Hospital, Boulogne-Billancourt, France
| | - Thierry Clerici
- Department of Pathology, Ambroise Paré Hospital, Boulogne-Billancourt, France
| | - Ute Zimmermann
- Department of Pathology, Ambroise Paré Hospital, Boulogne-Billancourt, France
| | - Philippe Saiag
- Research Unit EA 4340 Biomarkers in Cancerology and in Hemato-oncology, University of Versailles-Saint-Quentin-en-Yvelines, Université Paris-Saclay, Boulogne-Billancourt, France; Department of Dermatology, Ambroise Paré Hospital, Boulogne-Billancourt, France
| | - Elisa Funck-Brentano
- Research Unit EA 4340 Biomarkers in Cancerology and in Hemato-oncology, University of Versailles-Saint-Quentin-en-Yvelines, Université Paris-Saclay, Boulogne-Billancourt, France; Department of Dermatology, Ambroise Paré Hospital, Boulogne-Billancourt, France
| |
Collapse
|
8
|
Aouidad I, Fraitag S, Leclerc-Mercier S, Sibon D, Bodemer C, Boccara O. Hidradénite eccrine neutrophilique sous azacitidine traitée par anti-IL1 : à propos d’un cas. Ann Dermatol Venereol 2017. [DOI: 10.1016/j.annder.2017.09.339] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
9
|
Aouidad I, Schneider P, Zmuda M, Gottlieb J, Viguier M. IgG4-Related Disease With Orbital Pseudotumors Treated With Rituximab Combined With Palpebral Surgery. JAMA Dermatol 2017; 153:355-356. [DOI: 10.1001/jamadermatol.2016.4854] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022]
Affiliation(s)
- Iman Aouidad
- Department of Dermatology, Assistance Publique-Hôpitaux de Paris (APHP), Saint-Louis Hospital, Paris VII Denis Diderot University, Paris, France
| | - Pierre Schneider
- Department of Dermatology, Assistance Publique-Hôpitaux de Paris (APHP), Saint-Louis Hospital, Paris VII Denis Diderot University, Paris, France
| | - Mathieu Zmuda
- Department of Ophthalmology, Fondation Ophtalmologique A. de Rothschild, Paris, France
| | - Jeremy Gottlieb
- Department of Dermatology, Assistance Publique-Hôpitaux de Paris (APHP), Saint-Louis Hospital, Paris VII Denis Diderot University, Paris, France
| | - Manuelle Viguier
- Department of Dermatology, Assistance Publique-Hôpitaux de Paris (APHP), Saint-Louis Hospital, Paris VII Denis Diderot University, Paris, France
| |
Collapse
|
10
|
Gottlieb J, Aouidad I, Schneider P, Demongeot C, Petit A, Galicier L, Bagot M, Zmuda M, Viguier M. Efficacité du rituximab combiné à la chirurgie pour une maladie à IgG4 à type de pseudo-tumeurs orbitaires. Ann Dermatol Venereol 2016. [DOI: 10.1016/j.annder.2016.09.179] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
|
11
|
Aouidad I, Brentano EF, Sei JF, Clerici T, Zimmermann U, Tchakerian A, Chaussade V, Saiag P. Sous évaluation par la biopsie du caractère invasif du mélanome de Dubreuilh : à partir de 92 patients traités chirurgie micrographique (Slow-Mohs) en collerette. Ann Dermatol Venereol 2013. [DOI: 10.1016/j.annder.2013.09.136] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
12
|
Aouidad I, Fite C, Marinho E, Deschamps L, Crickx B, Descamps V. A case report of bullous pemphigoid induced by dipeptidyl peptidase-4 inhibitors. JAMA Dermatol 2013; 149:243-5. [PMID: 23426497 DOI: 10.1001/jamadermatol.2013.1073] [Citation(s) in RCA: 49] [Impact Index Per Article: 4.5] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/27/2023]
|